Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum toxin injection modality for androgenetic alopecia
ChiCTR2400080190Phase 4Recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Jan 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial of neuronox in androgenetic alopecia (AGA) (2 arms), sponsored by West China Hospital of Sichuan University. Primary endpoint: Hair count. Started Jan 2024; status: recruiting.
02
Drugs
neuronox
03
Conditions
androgenetic alopecia (AGA)
Beyond the preview
Go deeper on ChiCTR2400080190.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400080190.